Ruconest conestat alfa: Phase II data

Top-line data from the open-label, Dutch Phase II OPERA trial in 25 asymptomatic HAE patients with a history of frequent attacks showed that once-weekly 50 U/kg Ruconest for 8 weeks reduced the averag...